An­oth­er im­munome­tab­o­lism deal? Johns Hop­kins spin­out Dra­cen lands $36M in­vest­ment from Deer­field

In the sec­ond fi­nanc­ing round an­nounced in one day for an im­munome­tab­o­lism start­up, Johns Hop­kins spin­out Dra­cen Phar­ma­ceu­ti­cals just wrapped up a $36 mil­lion in­vest­ment …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER